Study of BGB-11417 in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

October 24, 2022

Primary Completion Date

January 24, 2025

Study Completion Date

August 25, 2027

Conditions
LeukemiaLymphomaRefractory Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaSmall Lymphocytic LymphomaRelapsed Chronic Lymphocytic Leukemia
Interventions
DRUG

BGB-11417

Administered orally

Trial Locations (50)

100000

Peking University Third Hospital, Beijing

100003

Beijing Jishuitan Hospital, Beijing

100730

Beijing Hospital, Beijing

101100

Beijing Friendship Hospital, Capital Medical University(Tongzhou), Beijing

110004

Shengjing Hospital of China Medical University, Shenyang

130021

The First Hospital of Jilin University, Changchun

134099

Tonghua Center Hospital, Tonghua

200025

Rui Jin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai

200032

Affiliated Zhongshan Hospital of Fudan University, Shanghai

210009

Zhongda Hospital Southeast University, Nanjing

210029

Jiangsu Province Hospital, Nanjing

214122

Affiliated Hospital of Jiangnan University South Campus, Wuxi

221000

The Affiliated Hospital of Xuzhou Medical University, Xuzhou

225001

Northern Jiangsu Peoples Hospital, Yangzhou

230088

Anhui Provincial Cancer Hospital Aka West Branch of Anhui Province Hospital, Hefei

250021

Shandong Provincial Hospital, Jinan

250117

Shandong Cancer Hospital, Jinan

264000

Yantai Yuhuangding Hospital, Yantai

272000

Jining No Peoples Hospital West Branch, Jining

300020

Institute of Hematology and Hospital of Blood Disease, Tianjin

310003

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou

310022

Zhejiang Cancer Hospital, Hangzhou

315010

Ningbo First Hospital, Ningbo

330006

The First Affiliated Hospital of Nanchang University Branch Donghu, Nanchang

350014

Fujian Cancer Hospital, Fuzhou

362000

Quanzhou First Affliated Hospital of Fujian Medical University, Quanzhou

362018

The Second Affiliated Hospital of Fujian Medical University Donghai Campus, Quanzhou

363000

Zhangzhou Municipal Hospital of Fujian Province, Zhangzhou

410011

The Second Xiangya Hospital of Central South University, Changsha

410013

Hunan Cancer Hospital, Changsha

430030

Tongji Hospital of Tongji Medical College Huazhong University of Science and Technology, Wuhan

450000

Henan Cancer Hospital, Zhengzhou

471003

The First Affiliated Hospital of Henan University of Science and Technology, Luoyang

473000

Nanyang Central Hospital, Nanyang

510000

Zhujiang Hospital of Southern Medical University, Guangzhou

512000

Yuebei Peoples Hospital, Shaoguan

530021

The First Affiliated Hospital of Guangxi Medical University, Nanning

537000

Red Cross Hospital of Yulin City, Yulin

550004

Affiliated Hospital of Guizhou Medical University, Guiyang

570312

Hainan Cancer Hospital, Haikou

618000

Peoples Hospital of Deyang City, Deyang

635099

Dazhou Central Hospital, Dazhou

650100

Yunnan Cancer Hospital, Kunming

710068

Shaanxi Provincial Peoples Hospital, Xi'an

730030

Lanzhou University Second Hospital, Lanzhou

830000

Affiliated Cancer Hospital of Xinjiang Medical University, Ürümqi

844099

The First Peoples Hospital of Kashgar, Kashgar

010050

The Affiliated Hospital of Inner Mongolia Medical University, Hohhot

037008

The Third Peoples Hospital of Datong, Datong

030032

Shanxi Bethune Hospital, Taiyuan

Sponsors

Lead Sponsor

All Listed Sponsors
lead

BeiGene

INDUSTRY